M:NYSEMacy's Inc Analysis

Current price sits at $20, just below the $20.53 resistance and above the $17.93 support, with the 20‑day SMA ($19.26) and 50‑day SMA ($18.73) both under the market price, indicating a short‑term price edge. The RSI of 60 and a bullish MACD histogram (+0.003) suggest modest upward momentum, though the overall trend remains neutral. Valuation metrics flag a disconnect: the DCF‑derived fair value of $4.71 is far below the market, yielding an implied ~3% downside, while a low trailing PE of ~8.6 and a PB of 1.08 paint a classic value picture. The dividend yield of 3.8% with a 31% payout ratio appears sustainable given positive operating cash flow and modest free cash flow.
Fundamentally, revenue is slipping (‑1.1% YoY) and operating margins sit at just 7.5%, with a high debt‑to‑equity ratio (~115%) and beta above 1.3, driving a 30‑day volatility of ~33%. Recent material news—Berkshire Hathaway’s fresh stake in Macy’s and the board’s dividend declaration—adds short‑term sentiment support, but the looming Q1 earnings and the company’s exposure to the consumer‑cyclical sector keep the outlook cautious. The blend of overvaluation signals, elevated risk metrics, and limited growth prospects suggests a hold stance now, with a watchful eye on execution and macro conditions.